Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications (Q28077984)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27622299%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

5 references

28 April 2020

31 August 2020

29 October 2020

19 January 2021

14 July 2021

Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27622299%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

0 references

7 references

13 March 2019

23 March 2019

25 June 2019

19 September 2019

27 September 2019

27 November 2019

13 December 2019

biomedical investigative technique

1 reference

19 September 2019

1 reference

27 September 2019

1 reference

27 November 2019

1 reference

13 December 2019

RNA virus infectious disease

1 reference

1 July 2020

1 reference

1 reference

31 August 2020

1 reference

29 October 2020

neutralizing antibody

1 reference

19 January 2021

2 references

14 July 2021

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27622299%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Anthony T Newall

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27622299%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

author name string

Martin Friede

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27622299%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Mohamud Sheikh

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27622299%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Siranda Torvaldsen

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27622299%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

language of work or name

1 reference

9 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27622299%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

26 October 2016

6 references

28 April 2020

1 July 2020

31 August 2020

29 October 2020

19 January 2021

14 July 2021

7

1 reference

based on heuristic

inferred from page(s)

15 references

13 March 2019

23 March 2019

25 June 2019

19 September 2019

27 September 2019

27 November 2019

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27622299%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

28 April 2020

1 July 2020

31 August 2020

29 October 2020

19 January 2021

14 July 2021

34

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27622299%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

page(s)

5442-5448

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27622299%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

issue

45

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27622299%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

22 March 2020

copyright license

13 references

13 March 2019

23 March 2019

25 June 2019

19 September 2019

27 September 2019

27 November 2019

13 December 2019

28 April 2020

1 July 2020

31 August 2020

29 October 2020

19 January 2021

on focus list of Wikimedia project

14 July 2021

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Randomized controlled trials for influenza drugs and vaccines: a review of controlled human infection studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Neuraminidase inhibitors for preventing and treating influenza in adults and children

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

A common solution to group 2 influenza virus neutralization

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

A highly conserved neutralizing epitope on group 2 influenza A viruses

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Industrialization of mAb production technology: the bioprocessing industry at a crossroads

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Total Economic Consequences of an Influenza Outbreak in the United States

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Universal influenza vaccines: a realistic option?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Safety and Upper Respiratory Pharmacokinetics of the Hemagglutinin Stalk-Binding Antibody VIS410 Support Treatment and Prophylaxis Based on Population Modeling of Seasonal Influenza A Outbreaks

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Universal influenza vaccines: Shifting to better vaccines.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Preclinical pharmacokinetics of MHAA4549A, a human monoclonal antibody to influenza A virus, and the prediction of its efficacious clinical dose for the treatment of patients hospitalized with influenza A.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Immunological considerations for developing antibody therapeutics for Influenza A.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Broadly neutralizing influenza hemagglutinin stem-specific antibody CR8020 targets residues that are prone to escape due to host selection pressure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Changes in and shortcomings of drug stockpiling, vaccine development and related policies during outbreaks of avian influenza A H5N1, H1N1, and H7N9 among humans.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5357764

Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015

2 June 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.08.057

10.1016/J.VACCINE.2016.08.057

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27622299%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27622299%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

2 references